About   Help   FAQ
Apelatm1.2Brre
Targeted Allele Detail
Summary
Symbol: Apelatm1.2Brre
Name: apelin receptor early endogenous ligand; targeted mutation 1.2, Bruno Reversade
MGI ID: MGI:6118179
Synonyms: Eladelta
Gene: Apela  Location: Chr8:65481069-65489970 bp, - strand  Genetic Position: Chr8, 32.52 cM
Alliance: Apelatm1.2Brre page
Mutation
origin
Germline Transmission:  Earliest citation of germline transmission: J:244834
Parent Cell Line:  Not Specified (ES Cell)
Strain of Origin:  C57BL/6J
Mutation
description
Allele Type:    Targeted (Null/knockout)
Mutations:    Insertion, Intragenic deletion
 
Mutation detailsA loxP site was inserted into intron 2 and an FRT site flanked neomycin resistance gene cassette and a second loxP site into intron 3. The neo cassette was removed through subsequent flp-mediated recombination. Exon 3 was deleted through subsequent cre-mediated recombination. Exon 3 codes for the mature peptide, so this creates a null allele. (J:244834)
Phenotypes
Key:
hm homozygous ht heterozygous tg involves transgenes phenotype observed
cn conditional genotype  cx complex: > 1 genome feature ot other: hemizygous, indeterminate,... N normal phenotype
Genotype/
Background:
Allelic Composition
Genetic Background
Cell Line(s)
hm1  Disease Model
 
 
Phenotypes:
Affected Systems
show or hide all annotated terms Sex:
 
cardiovascular system
abnormal cardiovascular system morphology
abnormal glomerular capillary endothelium morphology
absent glomerular endothelium fenestra
glomerular capillary congestion
abnormal placental labyrinth vasculature morphology
abnormal vascular development
abnormal angiogenesis
abnormal dorsal aorta morphology
abnormal intersomitic artery morphology
absent vitelline blood vessels
absent cardiac outflow tract
abnormal heart tube morphology
pericardial edema
increased systemic arterial blood pressure
cellular
increased placenta apoptosis
maternal effect
embryo
embryo phenotype
N N
absent vitelline blood vessels
increased placenta apoptosis
embryonic growth retardation
decreased embryo weight
abnormal placenta morphology
abnormal placental labyrinth vasculature morphology
thin placenta labyrinth
abnormal syncytiotrophoblast morphology
abnormal visceral yolk sac morphology
pale yolk sac
growth/size/body
embryonic growth retardation
decreased embryo weight
homeostasis/metabolism
pericardial edema
increased urine protein level
mortality/aging
lethality, incomplete penetrance
renal/urinary system
renal/urinary system phenotype
N
abnormal glomerular capillary endothelium morphology
absent glomerular endothelium fenestra
glomerular capillary congestion
increased urine protein level
renal glomerular protein deposits
reproductive system
abnormal litter size
View phenotypes and curated references for all genotypes (concatenated display).
Disease models
Key:
disease model   expected model not found
Models:
Human Diseases
hm1
IDs
Expression
In Structures Affected by this Mutation: 12 anatomical structure(s)
Find Mice (IMSR)
Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
Carrying this Mutation:  Mouse Strains: 0 strains available      Cell Lines: 0 lines available
Carrying any Apela Mutation:  18 strains or lines available
References
Original:  J:244834 Ho L, et al., ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science. 2017 Aug 18;357(6352):707-713
All:  2 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/17/2024
MGI 6.24
The Jackson Laboratory